These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 11502618)
1. Lymphoma in a patient with rheumatoid arthritis receiving methotrexate treatment: successful treatment with rituximab. Stewart M; Malkovska V; Krishnan J; Lessin L; Barth W Ann Rheum Dis; 2001 Sep; 60(9):892-3. PubMed ID: 11502618 [TBL] [Abstract][Full Text] [Related]
2. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection. Miyazaki T; Fujimaki K; Shirasugi Y; Yoshiba F; Ohsaka M; Miyazaki K; Yamazaki E; Sakai R; Tamaru J; Kishi K; Kanamori H; Higashihara M; Hotta T; Ishigatsubo Y Am J Hematol; 2007 Dec; 82(12):1106-9. PubMed ID: 17654684 [TBL] [Abstract][Full Text] [Related]
3. EBV-associated synovial lymphoma in a chronically inflamed joint in rheumatoid arthritis receiving prolonged methotrexate treatment. Chim CS; Pang YY; Ooi GC; Mok MY; Shek TW Haematologica; 2006 Aug; 91(8 Suppl):ECR31. PubMed ID: 16923515 [TBL] [Abstract][Full Text] [Related]
4. B-cell lymphoma of the larynx in a patient with rheumatoid arthritis. Patiar S; Ramsden JD; Freeland AP J Laryngol Otol; 2005 Aug; 119(8):646-8. PubMed ID: 16102224 [TBL] [Abstract][Full Text] [Related]
5. [2-year complete remission after withdrawal of methotrexate in a rectal methotrexate-associated diffuse large B-cell lymphoma]. Ogasawara T; Kimura A; Yasuyama M; Ohtuka K; Aiba M; Kawauchi K Rinsho Ketsueki; 2007 Jun; 48(6):485-90. PubMed ID: 17633096 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series. Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542 [TBL] [Abstract][Full Text] [Related]
7. Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. Quartuccio L; De Re V; Fabris M; Marzotto A; Franzolini N; Gasparotto D; Caggiari L; Ferraccioli G; Scott CA; De Vita S Haematologica; 2006 May; 91(5):691-4. PubMed ID: 16670074 [TBL] [Abstract][Full Text] [Related]
8. Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment. Thonhofer R; Gaugg M; Kriessmayr M; Neumann HJ; Erlacher L Ann Rheum Dis; 2005 Jul; 64(7):1098-9. PubMed ID: 15958773 [No Abstract] [Full Text] [Related]
9. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491 [TBL] [Abstract][Full Text] [Related]
10. Two cases of methotrexate induced lymphomas in rheumatoid arthritis: an association with increased serum IgE. Kono H; Inokuma S; Matsuzaki Y; Nakayama H; Yamazaki J; Hishima T; Maeda Y J Rheumatol; 1999 Oct; 26(10):2249-53. PubMed ID: 10529149 [TBL] [Abstract][Full Text] [Related]
11. What is the role of rituximab in the treatment of rheumatoid arthritis? Atzeni F; Doria A; Turiel M; Sarzi-Puttini P Autoimmun Rev; 2007 Sep; 6(8):553-8. PubMed ID: 17854748 [TBL] [Abstract][Full Text] [Related]
12. Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate. Sibilia J; Lioté F; Mariette X Rev Rhum Engl Ed; 1998 Apr; 65(4):267-73. PubMed ID: 9599795 [TBL] [Abstract][Full Text] [Related]
13. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection. Lioté F; Pertuiset E; Cochand-Priollet B; D'Agay MF; Dombret H; Numéric P; D'Anglejan G; Kuntz D J Rheumatol; 1995 Jun; 22(6):1174-8. PubMed ID: 7674250 [TBL] [Abstract][Full Text] [Related]
14. [Aggressive non-Hodgkin lymphoma in 3 patients with rheumatoid arthritis: discontinue the use of methotrexate]. van Poppel PC; Fijnheer R; Haverman JF; Sinniqe HA Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2351-6. PubMed ID: 19024068 [TBL] [Abstract][Full Text] [Related]
15. Lymphoma with regression after methotrexate withdrawal in a patient with rheumatoid arthritis. Role for the Epstein-Barr virus. Le Goff P; Chicault P; Saraux A; Baron D; Valls-Bellec I; Leroy JP Rev Rhum Engl Ed; 1998 Apr; 65(4):283-6. PubMed ID: 9599798 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [TBL] [Abstract][Full Text] [Related]
17. Malignant lymphoma associated with rheumatoid arthritis, developing shortly after initiation of oral methotrexate. Gono T; Shimojima Y; Hoshi K; Yamamoto K; Tokuda T; Shikama N; Matsuda M; Ikeda S Intern Med; 2004 Feb; 43(2):135-8. PubMed ID: 15005257 [TBL] [Abstract][Full Text] [Related]
18. Primary ovarian large B-cell lymphoma in patient with juvenile rheumatoid arthritis treated with low dose Methotrexate. Yildirim Y Gynecol Oncol; 2005 Apr; 97(1):249-52. PubMed ID: 15790469 [TBL] [Abstract][Full Text] [Related]
19. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis. Visvanathan S; Wagner C; Smolen J; St Clair EW; Hegedus R; Baker D; Keenan G Arthritis Rheum; 2006 Sep; 54(9):2840-4. PubMed ID: 16948115 [TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma]. Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]